Search Studies
Studying What Concerns Care Teams about Immune Therapy for Transplants
The purpose of this study is to learn what makes doctors decide if they should use a certain cancer treatment in people who have had organ transplants and serious skin cancer. We will survey patients, doctors, and ethics experts (people who help others figure out what is right or wrong when making tough decisions). If you join the study, you will be asked to take a survey about your thoughts on a certain type of cancer treatment.
Study Topics
Treating Hodgkin Lymphoma with Combination Immuno-oncology Therapy
The purpose of this study is to compare the effects, good and/or bad, of the study drugs, brentuximab vedotin and nivolumab (Bv-NIVO), to the usual treatment for people with Hodgkins Lymphoma to find out which is better.
Study Topics
Testing Different Treatment Doses for Newly Diagnosed Multiple Myeloma
Multiple myeloma is a type of cancer that starts in white blood cells. It is usually treated with drugs called isatuximab, lenalidomide, and dexamethasone. This study aims to test a lower dose of these drugs for people who are newly diagnosed with multiple myeloma. We want to see if the lower dose is safe and helpful.
Study Topics
Studying the Medicine Triapine with Radiation for Recurrent Brain Tumors
The purpose of this study is to find out if adding a medicine called triapine to radiation therapy is safe for people with brain tumors that have come back. Our researchers will study different amounts of triapine to see which is safest. The goal is to learn if this new treatment works better or worse than usual care.
Study Topics
Studying Radiation Plus Immune Therapy for Kidney Cancer
The purpose of this study is to see if adding radiation to immune therapy helps people with kidney cancer that has spread. We want to see if this new treatment keeps the cancer from getting worse longer than immune therapy alone. The goal is to find out which treatment works better. We are looking for volunteers with kidney cancer that has spread, and surgery is not currently recommended.
Study Topics
Studying a New Treatment Plan for Patients with Large B-cell Lymphoma or Grade IIIB Follicular Lymphoma
We are looking for volunteers with Grade IIIB Follicular or Relapsed/Refractory Diffuse Large B-cell Lymphoma. The purpose of this study is to see if we can reduce the chance of your cancer growing or spreading by adding more treatment to the usual therapy. We are doing this study to see if this new approach is better or worse than the usual approach for patients who are getting CAR T-cell therapy.
Study Topics
Studying Money Stress Among Patients with Leukemia
The purpose of this study is to see if helping people with money problems during cancer treatment can make them feel better and stay healthier. People in the study will answer questions about their health, feelings, and money. The goal is to find out if special help with money makes a difference.
Study Topics
Comparing Bone Marrow Cancer Treatment Combinations
The purpose of this study is to find out which treatment works best for people who have just been diagnosed with multiple myeloma and cannot have a stem cell transplant. The study compares different combinations of medicines to see which helps people the most. Researchers hope this will help improve care for people with this type of cancer.
Study Topics
Studying a New Treatment Combination for Mantle Cell Lymphoma
The purpose of this study is to learn more about a new medicine combination to help patients with a type of blood cancer called mantle cell lymphoma. We want to see if a new medicine called sonrotoclax combined with the medicine zanubrutinib works better than zanubrutinib alone. Volunteers in the study will be randomly assigned to get either the new medicine or a placebo along with zanubrutinib.
Study Topics
Studying a New Treatment for Kids and Teens with Leukemia
The purpose of this study is learn more about a new treatment for children, teens, and young adults with leukemia. The treatment uses regular cancer medicine plus special medicines called dasatinib or imatinib and blinatumomab. The goal is to see if this new combination works better and has fewer side effects than the usual treatment.
Study Topics
Studying New Treatments for Advanced Breast Cancer
The purpose of this study is to learn more about a new drug, MK-2870, alone or with another drug called pembrolizumab. We want to see how well they work compared to standard chemotherapy. The goal is to find out which treatment helps people live longer and feel better. This study is for volunteers with advanced breast cancer that cannot be removed by surgery.
Study Topics
Using Sonrotoclax to Treat Cancer
The purpose of this study to see how well the anticancer study drug currently known as sonrotoclax works in the treatment of a type of cancer called Waldenström's Macroglobulinemia.
Study Topics
Studying a New Medicine for Women's Reproductive Cancers
The goal of this study is to learn more about a new medicine called IMGN151. We want to see if it is safe and if it helps treat cancers that start in parts of a woman's body like the ovaries, uterus, cervix, or vagina. Doctors also want to know if the medicine can help slow down or shrink the cancer.
Study Topics
Studying the Drug CB-011 for Treatment of Multiple Myeloma
The purpose of this study is to learn more about the study drug CB-01. We want to see if it is safe and helpful for treating people with a type of blood cancer called multiple myeloma that has come back or did not respond to other treatments. This drug uses special cells from a healthy donor to find and kill cancer cells.
Study Topics
Studying a New Medicine for B-cell Non-Hodgkin Lymphoma
The purpose of this study is to learn more about a new medicine called AZD0486. This medicine is for people with a type of cancer called B-cell non-Hodgkin lymphoma that has come back or did not get better with other treatments. The goal is to see if this medicine is safe and if it helps shrink or stop the cancer.
Study Topics
A Study of the Drug ABBV-383 for Treatment of Multiple Myeloma
Multiple myeloma is a type of blood cancer. The purpose of this study is to find out if the study drug ABBV-383 can be safely used with other treatments for this type of cancer. We want to find out the safest dose of the study drug when combined with these treatments. We also want to see if these combinations help patients whose cancer has returned or didn't respond to previous treatments.
Study Topics
Studying the Medicine BLEXIMENIB for Patients with Acute Myeloid Leukemia
The purpose of this study is to learn more about a new medicine called BLEXIMENIB. We want to see if it works better when added to two other medicines for people with a kind of blood cancer called acute myeloid leukemia (AML). This study is for people with changes in the KMT2A or NPM1 gene, who are not able to get stronger chemotherapy.
Study Topics
Testing Ways to Find People for Blood Cancer Screening
The purpose of this study is to test recruitment methods to find and sign up people for a blood screening study. The results will help us decide if we can do a bigger study later. You are invited to join because you are Black and/or African American, live in Charlotte, NC or nearby, and are at least 30 years old. This study will also check how many people have a blood condition that might lead to blood cancer.
Study Topics
Minority Health Screening and Prevention Cancer Cancer: Blood
Studying a New Cancer Treatment for Patients with Blood Cancer
The purpose of this study is to learn more about a new treatment for patients with blood cancer. We want to see if the treatment called AZD0486 when used alone or with other cancer treatment, is safe and useful. We are looking for volunteers with a one of these types of blood cancers: mantle cell lymphoma, chronic lymphocytic leukemia, or small lymphocytic lymphoma. The study team will provide more information.
Study Topics
Studying the Drug REGN5678 for Patients with Prostate Cancer
The purpose of this study is to learn more about a treatment for patients with prostate cancer. We want to see if the study drug called REGN4336 is safe and useful for patients with castration-resistant prostate cancer that has spread to other parts of the body. Study team will provide more information.
Study Topics